News

HDA UK Media and Political Bulletin – 9 April 2021

Media Summary

NHS ‘evaluating’ threat of fraud in pandemic delivery service

Chemist and Druggist, Valeria Fiore and Grace Lewis, 8 April 2021

The NHS Counter Fraud Authority (NHS CFA) is reviewing potential threats to the pandemic delivery service. The NHS wants to tackle fraud in pharmacies and improve weaknesses in the systems that could allow fraud to take place.

The pandemic delivery service for clinically extremely vulnerable (CEV) patients ended on 31st March, but the service is still available for people who have been notified of the need to self-isolate by NHS Test and Trace.

The Department of Health and Social Care (DH) published a new counter-fraud strategic plan last week, which did not explicitly mention pharmacy fraud. However, the strategy alluded to the DH’s plan of introducing measures to combat certain types of fraud affecting pharmacies, such as prescription fraud. A spokesperson for the NHS CFA confirmed that actions would target fraudulent claims made by contractors and patients alike.

Parliamentary Coverage

 There was no parliamentary coverage today.

 

Full Coverage

NHS ‘evaluating’ threat of fraud in pandemic delivery service

Chemist and Druggist, Valeria Fiore and Grace Lewis, 8 April 2021
The NHS Counter Fraud Authority (NHS CFA) is reviewing “some possible threats and vulnerabilities within the pandemic delivery service”, it has told C+D.

 

The NHS CFA is “aware” of some issues with the service, which was introduced for the first time in April last year, and “remains vigilant in case any additional threats emerge”, the spokesperson added.

 

It considers a “threat” as a “person or group, object or activity” that could commit fraud against the NHS in England, the spokesperson said. Instead, a “vulnerability” is a weakness in the system that “may allow fraud to occur”.

“We remain committed to evaluating the threats and vulnerabilities and finding solutions to mitigate them,” the spokesperson added.

 

The pandemic delivery service for clinically extremely vulnerable (CEV) patients ended on March 31, but the service is still available for people who have been notified of the need to self-isolate by NHS Test and Trace. This is currently commissioned until June 31.

 

In response to a written question in parliament, pharmacy minister Jo Churchill said last month (March 23) that pharmacy contractors and dispensing doctors had claimed for 3,477,259 deliveries to shielded patients between April and December 2020.

 

Tackling fraud in pharmacy “a priority”

 

The Department of Health and Social Care (DH) published a new counter-fraud strategic plan last week (March 30), in which it did not specifically mention pharmacy fraud.

 

However, the strategy alluded to the DH’s plan of introducing “preventative ways of permanently eradicating” certain types of fraud, such as prescription fraud.

 

A spokesperson for the DH told C+D that “tackling fraud within the pharmacy sector remains a priority and the NHS CFA has engaged with pharmacists to understand the types of fraud that take place”.

 

“We are introducing real time exemption checking (RTEC) technology so pharmacists can verify if patients are exempt from prescription charges,” the spokesperson added.

 

An NHS CFA spokesperson told C+D that counter-fraud actions in the pharmacy sector involve fraud committed by both contractors and patients.

 

In 2018, the DH said it would crack down on pharmacy contractor fraud, which it said was “impacting heavily” on the total fraud bill for the NHS.

 

However, a 2019 C+D investigation revealed that only one pharmacy contractor had been sanctioned for fraud against the NHS in a two-year period.

HDA UK Media and Political Bulletin – 9 April 2021

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?